Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to determine whether the addition of an investigational medication, axitinib, to radiation therapy will improve the outcome of treatment in patients, above the age of 70.
Epistemonikos ID: b55b9a3749a796ec853c1aaeb644fddd557f8602
First added on: May 10, 2024